Study on Serum Proteins in Women with Silicone Implants and Connective Tissue Disease
Author Information
Author(s): Csako Gyorgy, Costello Rene, Shamim Ejaz A, O'Hanlon Terrance P, Tran Anthony, Clauw Daniel J, Williams H James, Miller Frederick W
Primary Institution: National Institutes of Health
Hypothesis
Are serum protein levels altered in women with silicone implants who develop connective tissue disease compared to those without implants?
Conclusion
The study found no significantly increased risk of monoclonal gammopathy in women with silicone implants, but they had lower serum globulin and immunoglobulin levels.
Supporting Evidence
- Women with silicone implants had significantly lower serum total protein and immunoglobulin levels.
- No significant difference in paraproteinemia rates between women with and without silicone implants.
- The study included a total of 148 women, with 74 in each primary group.
Takeaway
Women with silicone breast implants have lower protein levels in their blood, but having these implants doesn't seem to make them more likely to have certain blood problems.
Methodology
This retrospective case-control study compared serum protein levels in women with silicone implants and connective tissue disease to matched controls without implants.
Potential Biases
Potential selection bias due to matching criteria and retrospective design.
Limitations
The study had small sample sizes and lacked long-term follow-up on the development of paraproteins.
Participant Demographics
74 women with silicone implants and CTD, matched with 74 without implants, primarily White.
Statistical Information
P-Value
0.06
Confidence Interval
95% confidence interval, 0.51–6.45
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website